Identification of N-Terminally Diversified GLP-1R Agonists Using Saturation Mutagenesis and Chemical Design
Name
acschembio.0c00722.pdf
Description
Published version
Size
3.39 MB
Format
Unknown
Checksum (MD5)
694af03e2b872296fc8afdea6dde4585
Author(s)
Longwell, Chelsea K.
Hanna, Stephanie
Hartrampf, Nina
Sperberg, R. Andres Parra
Huang, Po-Ssu
Pentelute, Bradley L.
Cochran, Jennifer R.
Date Issued
December 2020
Journal
ACS Chemical Biology
Publisher
American Chemical Society (ACS)
Citation
Longwell, Chelsea K, Hanna, Stephanie, Hartrampf, Nina, Sperberg, R Andres Parra, Huang, Po-Ssu et al. 2021. "Identification of N-Terminally Diversified GLP-1R Agonists Using Saturation Mutagenesis and Chemical Design." ACS Chemical Biology, 16 (1).
Version
Final published version
Abstract
© The glucagon-like peptide 1 receptor (GLP-1R) is a class B G-protein coupled receptor (GPCR) and diabetes drug target expressed mainly in pancreatic β-cells that, when activated by its agonist glucagon-like peptide 1 (GLP-1) after a meal, stimulates insulin secretion and β-cell survival and proliferation. The N-terminal region of GLP-1 interacts with membrane-proximal residues of GLP-1R, stabilizing its active conformation to trigger intracellular signaling. The best-studied agonist peptides, GLP-1 and exendin-4, share sequence homology at their N-terminal region; however, modifications that can be tolerated here are not fully understood. In this work, a functional screen of GLP-1 variants with randomized N-terminal domains reveals new GLP-1R agonists and uncovers a pattern whereby a negative charge is preferred at the third position in various sequence contexts. We further tested this sequence-structure-activity principle by synthesizing peptide analogues where this position was mutated to both canonical and noncanonical amino acids. We discovered a highly active GLP-1 analogue in which the native glutamate residue three positions from the N-terminus was replaced with the sulfo-containing amino acid cysteic acid (GLP-1-CYA). The receptor binding and downstream signaling properties elicited by GLP-1-CYA were similar to the wild type GLP-1 peptide. Computational modeling identified a likely mode of interaction of the negatively charged side chain in GLP-1-CYA with an arginine on GLP-1R. This work highlights a strategy of combinatorial peptide screening coupled with chemical exploration that could be used to generate novel agonists for other receptors with peptide ligands.
MIT Department
Massachusetts Institute of Technology. Department of Chemistry
Massachusetts Institute of Technology. Center for Environmental Health Sciences
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1021/acschembio.0c00722
